Ad is loading...
KOD
Price
$5.53
Change
+$0.23 (+4.34%)
Updated
Nov 15 closing price
130 days until earnings call
RXRX
Price
$6.17
Change
-$0.73 (-10.56%)
Updated
Nov 15 closing price
107 days until earnings call
Ad is loading...

KOD vs RXRX

Header iconKOD vs RXRX Comparison
Open Charts KOD vs RXRXBanner chart's image
Kodiak Sciences
Price$5.53
Change+$0.23 (+4.34%)
Volume$596.87K
CapitalizationN/A
Recursion Pharmaceuticals
Price$6.17
Change-$0.73 (-10.56%)
Volume$10.54M
CapitalizationN/A
KOD vs RXRX Comparison Chart
Loading...
KOD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
KOD vs. RXRX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KOD is a Sell and RXRX is a StrongSell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (KOD: $5.53 vs. RXRX: $6.18)
Brand notoriety: KOD and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KOD: 217% vs. RXRX: 207%
Market capitalization -- KOD: $290.96M vs. RXRX: $1.77B
KOD [@Biotechnology] is valued at $290.96M. RXRX’s [@Biotechnology] market capitalization is $1.77B. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KOD’s FA Score shows that 1 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • KOD’s FA Score: 1 green, 4 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, KOD is a better buy in the long-term than RXRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KOD’s TA Score shows that 3 TA indicator(s) are bullish while RXRX’s TA Score has 4 bullish TA indicator(s).

  • KOD’s TA Score: 3 bullish, 4 bearish.
  • RXRX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, KOD is a better buy in the short-term than RXRX.

Price Growth

KOD (@Biotechnology) experienced а +12.40% price change this week, while RXRX (@Biotechnology) price change was -13.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

KOD is expected to report earnings on Mar 27, 2025.

RXRX is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($1.77B) has a higher market cap than KOD($291M). KOD YTD gains are higher at: 81.908 vs. RXRX (-37.373). KOD has higher annual earnings (EBITDA): -170.71M vs. RXRX (-348.35M). RXRX has more cash in the bank: 474M vs. KOD (219M). KOD has less debt than RXRX: KOD (75.8M) vs RXRX (89.9M). RXRX has higher revenues than KOD: RXRX (48.6M) vs KOD (0).
KODRXRXKOD / RXRX
Capitalization291M1.77B16%
EBITDA-170.71M-348.35M49%
Gain YTD81.908-37.373-219%
P/E RatioN/AN/A-
Revenue048.6M-
Total Cash219M474M46%
Total Debt75.8M89.9M84%
FUNDAMENTALS RATINGS
KOD: Fundamental Ratings
KOD
OUTLOOK RATING
1..100
46
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KODRXRX
RSI
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bullish Trend 6 days ago
86%
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 7 days ago
84%
Bullish Trend 7 days ago
83%
Declines
ODDS (%)
Bearish Trend 25 days ago
89%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
88%
View a ticker or compare two or three
Ad is loading...
KOD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RRGRX7.300.02
+0.27%
DWS RREEF Global Real Estate Secc R6
IUERX24.72-0.20
-0.80%
JPMorgan International Focus R2
LVAQX20.06-0.18
-0.89%
LSV Small Cap Value Investor
OIGAX35.91-0.44
-1.21%
Invesco Oppenheimer International Gr A
CGLIX17.40-0.24
-1.36%
Calvert Global Equity Fund Class I

KOD and

Correlation & Price change

A.I.dvisor indicates that over the last year, KOD has been loosely correlated with CRSP. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if KOD jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KOD
1D Price
Change %
KOD100%
+4.34%
CRSP - KOD
44%
Loosely correlated
+0.85%
ABCL - KOD
42%
Loosely correlated
-3.99%
RXRX - KOD
42%
Loosely correlated
-10.64%
MGTX - KOD
41%
Loosely correlated
-2.41%
AVIR - KOD
41%
Loosely correlated
-2.72%
More

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been loosely correlated with BEAM. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if RXRX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
-10.64%
BEAM - RXRX
63%
Loosely correlated
-8.59%
CRSP - RXRX
56%
Loosely correlated
+0.85%
EXAI - RXRX
56%
Loosely correlated
-11.68%
PRME - RXRX
55%
Loosely correlated
-6.95%
NTLA - RXRX
54%
Loosely correlated
-7.61%
More